In this study we first demonstrated that their levels were elevated in IBD and then investigated whether genetic polymorphism could affect the expression of IL-23/Th17 pathway genes which led to different clinical features in Chinese IBD patients. This evidence concerns the gene IL37 and inflammatory bowel disease.